Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
|
|
CONCERT PHARMACEUTICALS, INC. (CNCE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/06/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
4
| van Heek Christi (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 25,651 shares
@ $0
Disposed/sold 16,400 shares
@ $0
Disposed/sold 25,000 options to buy
@ $12.96, valued at
$324k
Disposed/sold 10,000 options to buy
@ $13.29, valued at
$132.9k
Disposed/sold 10,000 options to buy
@ $19.59, valued at
$195.9k
Disposed/sold 10,000 options to buy
@ $11.02, valued at
$110.2k
Disposed/sold 14,144 options to buy
@ $9.16, valued at
$129.6k
Disposed/sold 10,250 options to buy
@ $4.26, valued at
$43.7k
Disposed/sold 7,003 options to buy
@ $5, valued at
$35k
|
|
| 03/06/2023 |
4
| Tung Roger D (CEO) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 756,427 shares
@ $0
Disposed/sold 57,916 shares
@ $0
Unknown transaction of 121,873 shares
@ $0
Unknown transaction of 13,274 shares
@ $0
Unknown transaction of 12,389 shares
@ $0
Disposed/sold 156,675 rights
@ $0
Disposed/sold 203,300 options to buy
@ $8.4, valued at
$1.7M
Disposed/sold 170,000 options to buy
@ $16.85, valued at
$2.9M
Disposed/sold 200,000 options to buy
@ $10.97, valued at
$2.2M
Disposed/sold 200,000 options to buy
@ $27.59, valued at
$5.5M
Disposed/sold 200,000 options to buy
@ $13.93, valued at
$2.8M
|
|
| 03/06/2023 |
4
| Stuart Nancy (COO) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 167,963 shares
@ $0
Disposed/sold 73,233 shares
@ $0
Disposed/sold 21,400 rights
@ $0
Disposed/sold 100,000 options to buy
@ $8.4, valued at
$840k
Disposed/sold 80,000 options to buy
@ $16.85, valued at
$1.3M
Disposed/sold 70,000 options to buy
@ $10.97, valued at
$767.9k
Disposed/sold 70,000 options to buy
@ $27.59, valued at
$1.9M
Disposed/sold 75,000 options to buy
@ $13.93, valued at
$1M
Disposed/sold 68,215 options to buy
@ $10.87, valued at
$741.5k
Disposed/sold 51,850 options to buy
@ $13.07, valued at
$677.7k
|
|
| 03/06/2023 |
4
| Munsie Jeffrey A (Chief Legal Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 38,350 shares
@ $0
Disposed/sold 49,699 shares
@ $0
Disposed/sold 100,000 options to buy
@ $9.87, valued at
$987k
Disposed/sold 42,430 options to buy
@ $10.87, valued at
$461.2k
Disposed/sold 51,850 options to buy
@ $13.07, valued at
$677.7k
|
|
| 03/06/2023 |
4
| JAEGER WILFRED E (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 5,125 shares
@ $0
Disposed/sold 16,400 shares
@ $0
Disposed/sold 10,000 options to buy
@ $16.42, valued at
$164.2k
Disposed/sold 10,000 options to buy
@ $12.96, valued at
$129.6k
Disposed/sold 10,000 options to buy
@ $13.29, valued at
$132.9k
Disposed/sold 10,000 options to buy
@ $19.59, valued at
$195.9k
Disposed/sold 10,000 options to buy
@ $11.02, valued at
$110.2k
Disposed/sold 10,000 options to buy
@ $9.16, valued at
$91.6k
Disposed/sold 10,250 options to buy
@ $4.26, valued at
$43.7k
|
|
| 03/06/2023 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 13,088 shares
@ $0
Disposed/sold 16,400 shares
@ $0
Disposed/sold 10,000 options to buy
@ $16.42, valued at
$164.2k
Disposed/sold 10,000 options to buy
@ $12.96, valued at
$129.6k
Disposed/sold 10,000 options to buy
@ $13.29, valued at
$132.9k
Disposed/sold 10,000 options to buy
@ $19.59, valued at
$195.9k
Disposed/sold 10,000 options to buy
@ $11.02, valued at
$110.2k
Disposed/sold 10,000 options to buy
@ $9.16, valued at
$91.6k
Disposed/sold 10,250 options to buy
@ $4.26, valued at
$43.7k
|
|
| 03/06/2023 |
4
| Hoeiland Jesper (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 5,125 shares
@ $0
Disposed/sold 16,400 shares
@ $0
Disposed/sold 25,000 options to buy
@ $11.02, valued at
$275.5k
Disposed/sold 10,000 options to buy
@ $9.16, valued at
$91.6k
Disposed/sold 10,250 options to buy
@ $4.26, valued at
$43.7k
|
|
| 03/06/2023 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 80,595 shares
@ $0
Disposed/sold 57,766 shares
@ $0
Disposed/sold 34,700 rights
@ $0
Disposed/sold 140,000 options to buy
@ $14.46, valued at
$2M
Disposed/sold 50,000 options to buy
@ $16.85, valued at
$842.5k
Disposed/sold 70,000 options to buy
@ $10.97, valued at
$767.9k
Disposed/sold 49,500 options to buy
@ $27.59, valued at
$1.4M
Disposed/sold 75,000 options to buy
@ $13.93, valued at
$1M
Disposed/sold 42,430 options to buy
@ $10.87, valued at
$461.2k
Disposed/sold 60,400 options to buy
@ $13.07, valued at
$789.4k
|
|
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
4
| Becker Marc A. (CFO) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 56,264 shares
@ $0
Disposed/sold 49,699 shares
@ $0
Disposed/sold 17,900 rights
@ $0
Disposed/sold 100,000 options to buy
@ $27.59, valued at
$2.8M
Disposed/sold 110,000 options to buy
@ $13.93, valued at
$1.5M
Disposed/sold 42,430 options to buy
@ $10.87, valued at
$461.2k
Disposed/sold 51,850 options to buy
@ $13.07, valued at
$677.7k
|
|
| 03/06/2023 |
4
| Auchincloss Thomas G (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 17,625 shares
@ $0
Disposed/sold 16,400 shares
@ $0
Disposed/sold 25,000 options to buy
@ $11.19, valued at
$279.8k
Disposed/sold 10,000 options to buy
@ $16.42, valued at
$164.2k
Disposed/sold 10,000 options to buy
@ $12.96, valued at
$129.6k
Disposed/sold 10,000 options to buy
@ $13.29, valued at
$132.9k
Disposed/sold 10,000 options to buy
@ $19.59, valued at
$195.9k
Disposed/sold 10,000 options to buy
@ $11.02, valued at
$110.2k
Disposed/sold 10,000 options to buy
@ $9.16, valued at
$91.6k
Disposed/sold 10,250 options to buy
@ $4.26, valued at
$43.7k
|
|
| 03/06/2023 |
4
| ALDRICH RICHARD (Director) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 342,100 shares
@ $0
Disposed/sold 16,400 shares
@ $0
Unknown transaction of 210,526 shares
@ $0
Unknown transaction of 44,351 shares
@ $0
Disposed/sold 10,000 options to buy
@ $16.42, valued at
$164.2k
Disposed/sold 10,000 options to buy
@ $12.96, valued at
$129.6k
Disposed/sold 10,000 options to buy
@ $13.29, valued at
$132.9k
Disposed/sold 15,940 options to buy
@ $19.59, valued at
$312.3k
Disposed/sold 10,000 options to buy
@ $11.02, valued at
$110.2k
Disposed/sold 23,260 options to buy
@ $9.16, valued at
$213.1k
Disposed/sold 40,432 options to buy
@ $4.26, valued at
$172.2k
|
|
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/06/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/06/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/06/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/06/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 03/06/2023 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 03/06/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 03/06/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 02/24/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|